Expertise in
24
conditions

Dr. Mario E. Lacouture

Dermatology
Sears Optical #C0865
1111 Franklin Ave, 
Garden City, NY 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
24
conditions
Sears Optical #C0865
1111 Franklin Ave, 
Garden City, NY 

Overview

Mario Lacouture is a Dermatologist practicing medicine in Garden City, New York.

Dr. Lacouture is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Autosomal Recessive Hypotrichosis, Hartsfield Syndrome, Alopecia Areata, and Basal Cell Skin Cancer.

He is actively involved in clinical research, co-authoring 283 peer reviewed articles and participating in 8 clinical trials. Dr. Lacouture is currently accepting new patients.

Specialties

Dermatology

Licenses

Dermatology in NY

Hospital Affiliations

Nyu Langone Hospitals

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
CareFirst
  • HMO
  • POS
  • PPO
CenterLight Healthcare
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetLife
  • PPO
MetroPlus Health
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Nippon Life
  • INSURANCE PLAN
Northwell Health
  • INSURANCE PLAN
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
The Wellness Plan Medical Centers
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
VNS Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 25 Less Insurance Carriers -

Locations

Sears Optical #C0865
1111 Franklin Ave, Garden City, NY 11530

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
Enrollment Status: Completed
Publish Date: August 18, 2026
Intervention Type: Behavioral
The PROTECT Study: A Phase II, Open-Label Trial of PROphylactic Skin Toxicity ThErapy With Clindamycin and Triamcinolone in Glioblastoma Patients Treated With Tumor Treating Fields
The PROTECT Study: A Phase II, Open-Label Trial of PROphylactic Skin Toxicity ThErapy With Clindamycin and Triamcinolone in Glioblastoma Patients Treated With Tumor Treating Fields
Enrollment Status: Active_not_recruiting
Publish Date: August 10, 2026
Intervention Type: Drug
Study Drugs: Clindamycin Phosphate, Triamcinolone Acetonide
Study Phase: Phase 2
Safety and Tolerability of Lower Scalp Cooling Temperatures to Prevent Doxorubicin Plus Cyclophosphamide and Paclitaxel-induced Alopecia in Breast Cancer Patients
Safety and Tolerability of Lower Scalp Cooling Temperatures to Prevent Doxorubicin Plus Cyclophosphamide and Paclitaxel-induced Alopecia in Breast Cancer Patients
Enrollment Status: Active_not_recruiting
Publish Date: June 04, 2026
Intervention Type: Device
Study Phase: Not Applicable
Phase II Study of IL-5-receptor-alpha-chain (IL-5Rα) Inhibition With Benralizumab for Eosinophil-Related Cutaneous Adverse Events in Cancer Patients
Phase II Study of IL-5-receptor-alpha-chain (IL-5Rα) Inhibition With Benralizumab for Eosinophil-Related Cutaneous Adverse Events in Cancer Patients
Enrollment Status: Completed
Publish Date: June 01, 2026
Intervention Type: Drug
Study Phase: Phase 2
A Prospective, Longitudinal Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer
A Prospective, Longitudinal Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 04, 2025
Intervention Type: Other, Behavioral
A Phase II Study to Evaluate the Safety and Efficacy of OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients
A Phase II Study to Evaluate the Safety and Efficacy of OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients
Enrollment Status: Unknown
Publish Date: March 04, 2024
Intervention Type: Drug
Study Phase: Phase 2
A Phase 1, Open-Label, Dose Escalation Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy Study of Topically Administered LUT014 in Metastatic Colorectal Cancer Patients With EGFR Inhibitor Induced Acneiform Lesions
A Phase 1, Open-Label, Dose Escalation Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy Study of Topically Administered LUT014 in Metastatic Colorectal Cancer Patients With EGFR Inhibitor Induced Acneiform Lesions
Enrollment Status: Completed
Publish Date: April 06, 2022
Intervention Type: Drug
Study Phase: Phase 1
Phase 1/2 Dose-Rising, Safety, Tolerability and Efficacy Study of Topical SOR007 for Cutaneous Metastases
Phase 1/2 Dose-Rising, Safety, Tolerability and Efficacy Study of Topical SOR007 for Cutaneous Metastases
Enrollment Status: Completed
Publish Date: November 05, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 7 Less Clinical Trials

283 Total Publications

Author Correction: Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.
Author Correction: Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.
Journal: Nature medicine
Published: September 02, 2026
Similar Doctors
Expertise in
17
conditions
Dr. Leon H. Kircik
Dermatology
Expertise in
17
conditions
Dr. Leon H. Kircik
Dermatology
Referral may be required

Clinical Pathology Associates

1425 Madison Ave, 
New York, NY 
 (17.1 miles away)
212-659-9530
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Leon Kircik is a Dermatologist practicing medicine in New York, New York. Dr. Kircik is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Acne, Plaque Psoriasis, Atopic Dermatitis, and Psoriasis. Dr. Kircik is currently accepting new patients.

Expertise in
23
conditions
Expertise in
23
conditions
Referral may be required
Before you request

Office

1275 York Ave Ste 407, 
New York, NY 
 (17.3 miles away)
646-888-6018
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Patricia Myskowski is a Dermatologist practicing medicine in New York, New York. Dr. Myskowski is highly rated in 23 conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), and Lymphomatoid Papulosis. Dr. Myskowski is currently accepting new patients.

Expertise in
9
conditions
Dr. Aimee S. Payne
Dermatology
Expertise in
9
conditions
Dr. Aimee S. Payne
Dermatology
Referral may be required

CUIMC/Herbert Irving Pavilion

161 Fort Washington Ave, 
New York, NY 
 (17.7 miles away)
914-768-8691
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Aimee Payne is a Dermatologist practicing medicine in New York, New York. Dr. Payne is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Pemphigus, Pemphigus Vulgaris, Pemphigus Foliaceus, and Bullous Pemphigoid. Dr. Payne is currently accepting new patients.

Frequently Asked Questions about Dr. Mario E. Lacouture

How do I make an appointment with Dr. Mario E. Lacouture?

You can book an appointment with Dr. Mario E. Lacouture by calling their office at 516-739-1141. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mario E. Lacouture a top-rated expert for Autosomal Recessive Hypotrichosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mario E. Lacouture is classified as an Elite expert for Autosomal Recessive Hypotrichosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mario E. Lacouture specialize in?

While Dr. Mario E. Lacouture is a Dermatology, they have specific expertise in Autosomal Recessive Hypotrichosis, Hartsfield Syndrome, and Alopecia Areata. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Mario E. Lacouture participate in research or clinical trials?

Yes. Dr. Mario E. Lacouture has published 283 articles and abstracts on conditions like Autosomal Recessive Hypotrichosis. You can view a list of Dr. Mario E. Lacouture's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mario E. Lacouture accept my insurance?

Dr. Mario E. Lacouture accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 516-739-1141 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lacouture's expertise for a condition
ConditionClose
View All 18 Advanced Conditions
View All 82 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile